Skip to main content

Advertisement

Log in

The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients with Gastric Adenocarcinoma

  • Original Research
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

High values of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are related with poor prognosis in patients with gastric cancer. However, this association has been rarely assessed in Hispanic populations that show important clinicopathological differences to Asian and Caucasian patients. In this study, we determined the prognostic value of these biomarkers in Hispanic patients from Costa Rica.

Materials and Methods

We retrieved data regarding pre-treatment NLR and PLR, as well as clinical variables from medical records of 381 consecutive gastric cancer patients treated in four major hospitals in Costa Rica between 2009 and 2012. Univariate and multiple Cox regression analyses were performed to assess the value of NLR and PLR as predictors of overall survival (OS) and disease-free survival (DFS). The best cutoff point was based on the maximization of the Log-rank test.

Results

Median follow-up was 13.21 months. In univariate analysis, a NLR ≥ 5 was associated with reduced DFS (hazard ratio (HR) 2.31; 95% confidence interval (CI) 1.78–3.00; p < 0.001) and poor OS (HR 2.24; 95% CI 1.72–2.92; p < 0.001). Similarly, a PLR ≥ 350 was associated with worse DFS (HR 2.28; 95% CI 1.70–3.06; p < 0.001) and poor OS (HR 2.33; 95% CI 1.73–3.13; p < 0.001). After adjustment for potential confounders, multivariate analysis revealed that only the NLR ≥ 5 was independently associated with worse DFS (HR 1.97; 95% CI 1.44–2.47) and OS (HR 1.59; 95%CI 1.15–2.28).

Conclusions

NLR ≥ 5 was independently associated with worse OS and DFS in Hispanic patients with gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. International Agency for Research on Cancer. World Health Organization. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed on August 1st, 2017.

  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

    Article  Google Scholar 

  3. Registro Nacional de Tumores. Ministerio de Salud, Gobierno de Costa Rica. Available at: https://www.ministeriodesalud.go.cr/index.php/vigilancia-de-la-salud/estadisticas-y-bases-de-datos/estadisticas/estadistica-de-cancer-registro-nacional-tumores?limit=5. Accessed on May 26th, 2018.

  4. Sierra M, Cueva P, Bravo LE, Forman D. Stomach cancer burden in central and South America. Cancer Epidemiol. 2016;44:S62–73.

    Article  Google Scholar 

  5. Carioli G, La Vecchia C, Bertuccio P, et al. Cancer mortality predictions for 2017 in Latin America. Ann Oncol. 2017;28:2286–97.

    Article  CAS  Google Scholar 

  6. Yao JC, Tseng JF, Worah S, Hess KR, Mansfield PF, Crane CH, et al. Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: analysis of a single institution's experience over 15 years. J Clin Oncol. 2005;23:3094–103.

    Article  Google Scholar 

  7. Rajabi B, Corral JC, Hakim N, Mulla ZD. Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus white non-Hispanic. Gastric Cancer. 2012;15:405–13.

    Article  Google Scholar 

  8. Duma N, Sanchez LJ, Castro YS, Jennis AA, McCain D, Gutierrez ME, et al. Gastric adenocarcinoma: clinicopathologic differences among Hispanics and non-Hispanic whites. A single Institution’s experience over 14 years. Ann Gastroenterol. 2016;29:325–31.

    PubMed  PubMed Central  Google Scholar 

  9. Al-Rafaie WB, Tseng JF, Gay G, et al. The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma. Results from the National Cancer Data Base. Cancer. 2008;113:461–9.

    Article  Google Scholar 

  10. Ramos-Esquivel A, Rodriguez-Porras L, Porras J. Neutrophil to lymphocyte ration and platelet to lymphocyte ratio as prognostic factors in non-metastatic breast cancer patients from a Hispanic population. Breast Dis. 2017;37:1–6.

    Article  CAS  Google Scholar 

  11. Wu J, Jiang M, Qin Y, et al. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer. Clin Chem Acta. 2018;481:20–4.

    Article  CAS  Google Scholar 

  12. Contal C, O’Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal. 1999;30:253–70.

    Article  Google Scholar 

  13. Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–50.

    Article  CAS  Google Scholar 

  14. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454:436–44.

    Article  CAS  Google Scholar 

  15. Finn OJ. Cancer immunology. N Engl J Med. 2008;358:2704–15.

    Article  CAS  Google Scholar 

  16. Gay L, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011;11:123–34.

    Article  CAS  Google Scholar 

  17. Zhang X, Zhang W, Feng L. Prognostic significance of neutrophil lymphocyte ratio in patients with gastric cancer: a meta-analysis. PLoS One. 2014;9:e111906.

    Article  Google Scholar 

  18. Templeton AJ, McNamara MG, Seruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.

    Article  Google Scholar 

  19. XIn-Ji Z, Yong-Gang L, Xiao-Jun S, et al. The prognostic role of neutrophils to lymphocytes ratio and platelet count in gastric cancer: a meta-analysis. Int J Surg. 2015;21:84–91.

    Article  Google Scholar 

  20. Lieto E, Galizia G, Auricchio A, Cardella F, Mabilia A, Basile N, et al. Preoperative neutrophil to lymphocyte ratio and lymphocyte to monocyte ratio are prognostic factors in gastric cancers undergoing surgery. J Gastrointest Surg. 2017;21:1764–74.

    Article  Google Scholar 

  21. Altman DG, Lausen B, Sauerbrei W, Shumacher M. Danger of using optimal cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst. 1994;86:829–35.

    Article  CAS  Google Scholar 

  22. Choi JH, Suh YS, Choi Y, et al. Comprehensive analysis of the neutrophil-to-lymphocyte ratio for preoperative prognostic prediction nomogram in gastric cancer. World J Surg. 2018; https://doi.org/10.1007/s00268-018-4510-4.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Ramos-Esquivel.

Ethics declarations

The study was approved by the Ethical Scientific Committee of the University of Costa Rica (no. 817-B2-371) and the Institutional Scientific Ethics Committee of the Caja Costarricense del Seguro Social (R013-SABI-00048). *The abstract of this manuscript was presented at the ESMO XX World Congress on Gastrointestinal Cancer 2018, Barcelona, Spain.

Conflict of Interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ramos-Esquivel, A., Cordero-García, E., Brenes-Redondo, D. et al. The Neutrophil-Lymphocyte Ratio Is an Independent Prognostic Factor for Overall Survival in Hispanic Patients with Gastric Adenocarcinoma. J Gastrointest Canc 50, 728–734 (2019). https://doi.org/10.1007/s12029-018-0134-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-018-0134-z

Keywords

Navigation